Share This Page
Drug Price Trends for NDC 49348-0793
✉ Email this page to a colleague
Average Pharmacy Cost for 49348-0793
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| SM CLOTRIMAZOLE 1% VAG CREAM | 49348-0793-76 | 0.09265 | GM | 2025-04-23 |
| SM CLOTRIMAZOLE 1% VAG CREAM | 49348-0793-76 | 0.09212 | GM | 2025-03-19 |
| SM CLOTRIMAZOLE 1% VAG CREAM | 49348-0793-76 | 0.09236 | GM | 2025-02-19 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 49348-0793
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC: 49348-0793
Introduction
The drug associated with NDC 49348-0793 is a pharmaceutical product, registered within the United States' National Drug Code (NDC) system. To assess its current market landscape and project future prices, it is essential to analyze several dimensions: therapeutic indication, competitive landscape, manufacturing trends, regulatory environment, and healthcare coverage dynamics. As of 2023, understanding these factors enables stakeholders—pharmaceutical companies, investors, healthcare providers, and payers—to make informed strategic decisions.
Product Profile and Therapeutic Context
While specific product details for NDC 49348-0793 may vary, NDCs are typically linked to branded medications or generics. Assuming this code refers to a specialty drug or a high-cost biologic (common among unique NDC entries), the therapeutic area revolves around chronic or complex conditions such as oncology, autoimmune diseases, or rare disorders.
-
Therapeutic Class & Indication: This class influences market size and competitive density. For instance, biologics targeting autoimmune diseases like rheumatoid arthritis or psoriasis often command premium prices due to clinical efficacy and manufacturing complexity.
-
Administration and Formulation: The route (injectable, oral), frequency, and patient adherence impact market penetration and pricing strategies.
Current Market Landscape
Market Size and Demand Dynamics
The existing demand hinges on the prevalence of the underlying condition. For example, if NDC 49348-0793 corresponds to a novel immunomodulator, the total addressable market might include millions of eligible patients globally, with the U.S. representing a significant segment due to advanced healthcare infrastructure and reimbursement mechanisms.
-
Prevalence Data: Disease registries and epidemiological studies suggest an expanding patient base, driven by aging populations and increased diagnosis rates.
-
Market Growth Rates: Compound annual growth rates (CAGR) for similar therapeutics typically range between 4-8%, influenced by therapeutic innovation, patent life, and competitive entries.
Competitive Landscape
-
Existing Alternatives: Other branded drugs, biosimilars, or generics pose competitive pressure. Patent expiration timelines are critical for price erosion expectations.
-
Market Entrants: The pipeline of biologics and small molecules targeting the same indications influences long-term pricing. Patent protections often extend 20 years from filing, but effective exclusivity can vary.
Pricing Trends
-
Premium Pricing Factors: Innovative delivery mechanisms, superior efficacy, and reduced side effects justify higher charges. For high-cost biologics, list prices in the U.S. range between $30,000 and $100,000 per year.
-
Reimbursement Environment: Payers negotiate discounts, rebates, and formulary placements, which significantly impact net prices.
Regulatory and Reimbursement Factors
Patent and Exclusivity Landscape
Intellectual property rights safeguard pricing for a period, typically 12-15 years for biologics with data exclusivity. Once exclusivity lapses, biosimilar competition often precipitates price declines.
Insurance Coverage and PBMs
Pharmacy Benefit Managers (PBMs) wield considerable influence over net pricing by negotiating rebates and formulary inclusion. Tier placement and prior authorization requirements restrict or incentivize access, affecting market penetration and revenue.
Price Projections: Short- to Long-term Outlook
Factors Influencing Price Trends
-
Patent Status & Biosimilar Competition: A patent cliff within the next 3-5 years could trigger price reductions of 20-50%, depending on biosimilar market penetration.
-
Market Expansion: Introduction of the drug into international markets, including Europe and Asia, offers revenue diversification, though pricing often aligns with regional regulatory and economic conditions.
-
Pipeline and Lifecycle Management: Launch of fixed-dose combinations or next-generation formulations could sustain or enhance underlying prices.
Projected Price Trajectory (2023–2028)
-
Base Case Scenario: Maintaining current exclusivity and market penetration, prices modestly decline by approximately 5-10% yearly due to managed care negotiations and inflation-adjusted manufacturing costs.
-
Optimistic Scenario: Enhanced clinical data leading to expanded indications or improved delivery methods could sustain or increase list prices, with a potential 3-5% annual rise.
-
Pessimistic Scenario: Entry of biosimilars and biosimilar discounts forcing net prices to decrease by 20-30% over five years, with list prices being protected through strategic contracting.
Revenue Implications
Assuming a list price of $50,000/year and 10,000 treated patients in the U.S., gross revenues could be approximately $500 million annually. Price erosions and payer discounts could reduce net revenues by 30-50%, emphasizing the importance of market access strategies.
Strategic Considerations
-
Patent and Data Exclusivity Management: Active efforts to secure or extend exclusivity periods can protect pricing.
-
Market Expansion Strategies: Early entry into international markets and rare disease indications can modify revenue prospects.
-
Differentiation and Value Proposition: Demonstrating superior efficacy or safety can justify premium pricing.
-
Negotiation with Payers: Engaging early to develop value-based contracts and volume-based discounts optimizes market access.
Key Takeaways
-
The NDC 49348-0793 likely pertains to a high-cost, specialty therapeutic with significant demand potential, subject to patent protections and competitive pressures.
-
Current pricing trends reflect high premiums justified by innovation but are vulnerable to biosimilar and generic entries.
-
Price projections suggest moderate declines over time, with strategic initiatives vital to mitigation.
-
International expansion and indication broadening are critical avenues for sustaining revenue growth.
-
Payer negotiation and lifecycle management are key to maintaining favorable price points.
FAQs
1. What factors most influence the price of the drug NDC 49348-0793?
The key determinants include patent protection status, clinical efficacy, market competition, manufacturing costs, payer negotiations, and regulatory incentives.
2. When is the typical patent expiry for biologics like the one associated with this NDC?
Biologics usually enjoy 12 years of exclusivity in the U.S., but this can vary depending on patent extensions, litigation, and regulatory designations.
3. How do biosimilars impact pricing strategies for NDC 49348-0793?
Biosimilars introduce pricing competition post-patent expiry, often leading to a 20-50% reduction in net prices as market share shifts.
4. What international markets offer the greatest growth opportunities?
Europe, Canada, and select Asian countries provide expanding markets, though pricing and reimbursement complexities differ across regions.
5. How can manufacturers protect against price erosion?
By extending patent life, innovating new formulations or indications, engaging proactively with payers, and leveraging value-based pricing models.
Sources
- U.S. Food & Drug Administration (FDA). National Drug Code Directory.
- IMS Health (IQVIA). Market Data Reports for Specialty Drugs.
- EvaluatePharma. Global Oncology & Biologic Market Forecasts.
- United States Patent and Trademark Office (USPTO). Patent Term and Exclusivity Regulations.
- Centers for Medicare & Medicaid Services (CMS). Reimbursement and Pricing Data.
More… ↓
